The innovations in science and technology as a demand for bio-better medicines in Europe.
The purpose of this review is to address the role of the scientific excellence of innovative medicines as the key element in the development process in Greece. The collected statistical information and data on the absorbability of funds for research of innovative medicines, diagnostics, and advanced drug delivery systems pointed out that the Greek scientists could take advantage of the "Horizon 2020" on the continuity of their investigation, whilst how the accumulation of knowledge at Greek universities and research foundations could be translated into industrial products with added value, safe and effective for the European consumers. In conclusion, this review also is considered to provide the potential benefits in order to adapt the signaling of the "Horizon 2020" for the development of a bio-better Europe based on scientific inspirations. This approach could be considered as an interplay between countries and even between the north and west located countries in the European landscape.